<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

CU Cancer Center News and Stories

Radiation

Research    Lung Cancer    Radiation    Medical Oncology    Targeted Therapies

Weeding the Garden: Fresh Evidence that Local Radiation Can Help Targeted Therapies in the Fight Against Lung Cancer

It’s been a dozen years since D. Ross Camidge, MD, PhD, of the University of Colorado Cancer Center and his colleagues first published on the use of tightly-focused radiation to attack isolated active cancer sites in lung cancer patients who otherwise were responding well to targeted therapies. In the years since, that breakthrough has transformed cancer care.


Author Mark Harden | Publish Date June 12, 2024
Full Story

Patient Care    Brain and Spinal Cancer    Oncology    Radiation

Brain Cancer Patient Recruits the CU Cancer Center for the Fight of His Life

Alex Cooper relishes a challenge. Armed with a New Yorker’s moxie, an entrepreneur’s savvy, and an athlete’s determination, he has launched startups, has competed in Ironman triathlons, and offers motivational messages in blogs, videos, and social media posts as the “Iron CEO.”


Author Mark Harden | Publish Date December 04, 2023
Full Story

Research    Pediatric Cancer    Sarcoma    Radiation

Study Shows that Equivocal Scan Results Don’t Predict Higher Risk of Pediatric Cancer Relapse

For many pediatric cancer patients and their families, “scanxiety” is a very real and very scary feeling – the worry that can precede scans before treatment, and the uncertainty stemming from scans after treatment is completed.


Author Rachel Sauer | Publish Date April 05, 2023
Full Story

Research    Lung Cancer    Radiation   

Research Shows Targeted Therapy Allows Certain Lung Cancer Patients to Avoid Whole-Brain Radiation

Whole-brain radiation therapy used to treat brain metastases is a significant cancer treatment that, while generally well-tolerated, can have serious long-term side effects, including dementia. Neither clinicians nor patients undertake it lightly.


Author Rachel Sauer | Publish Date March 29, 2023
Full Story

Community    Radiation

What is Radiation Therapy?

Oncologists have many tools they use to treat cancer, and one of the most commonly used is radiation therapy. In use since the early 1900s, radiation therapy uses high-energy particles or waves — including x-rays, gamma rays, electron beams, and protons — to destroy or damage cancer cells. The machine that delivers radiation therapy has a head that rotates 360 degrees, and patients lie on a special bench that swivels, allowing the radiation to be delivered from any angle.


Author Greg Glasgow | Publish Date July 13, 2022
Full Story

Lung Cancer    Radiation

Immune system damage may explain ineffectiveness of high-dose radiation against lung cancer

When it comes to using radiation against lung cancer, preliminary clinical studies were pretty clear: More is better. So why did a large phase 3 clinical trial find exactly the opposite – that stage III non-small cell lung cancer patients treated with higher doses of radiation actually had shorter overall survival than patients treated with lower-dose radiation?


Author Cancer Center | Publish Date June 27, 2019
Full Story

Clinical Trials    Radiation

New Investigator Award helps Tyler Robin, MD, PhD bring new clinical trials to Colorado

When Tyler Robin, MD, PhD, graduates from the Radiation Oncology Residency Program at University of Colorado Anschutz Medical Campus at the end of June, he won’t have to move far – after graduation, Robin will make the leap from trainee to researcher, joining CU faculty as an assistant professor in the CU School of Medicine Department of Radiation Oncology where he hopes to be involved with clinical trials testing new uses of radiation as a component of cancer care. A New Investigator Award from the Gynecologic Oncology Group (GOG) and NRG Oncology will help Robin expand the scope of his clinical trial involvement to the national level, while bringing new, innovative clinical trials to cancer patients in Colorado.


Author Cancer Center | Publish Date June 05, 2019
Full Story

Cancer    Radiation

Three Colorado studies show how tumors hijack the immune system to resist radiation therapy

More than a decade ago, radiation oncologists noticed a nifty phenomenon: Sometimes radiation used locally against a tumor could excite the immune system to attack cancer systemically throughout the body. It was as if the use of radiation had somehow awoken the immune system to the presence of cancer. Since then, a massive effort has been underway to harness this effect, hoping to create this systemic anti-cancer activity with combinations of radiotherapy and immunotherapy.


Author Cancer Center | Publish Date April 16, 2019
Full Story

CU Cancer Center In the News

Cancer Health

2024 Cancer Health 25: People Who Power Clinical Trials

news outletCancer Health
Publish DateJune 11, 2024

This year's Cancer Health 25 highlights the transformative power and promise of clinical trials. University of Colorado Cancer Center member Jessica McDermott, MD, MSCS, is leading clinical trials at both the CU Cancer Center and the Rocky Mountain Regional Veterans Affairs Medical Center. Additionally, she serves as the CU Cancer Center's deputy associate director for diversity and inclusion in clinical research.

Full Story
Cancer Network

Learning to “Aim High” Within Male-Dominated Fields in Public Health

news outletCancer Network
Publish DateJune 10, 2024

Cathy Bradley, PhD, deputy director of the Colorado University Cancer Center and dean of the Colorado School of Public Health, is a trailblazer in health economics. At a Breaking Barriers: Women in Oncology discussion, she shared insights on overcoming challenges as a woman in a male-dominated field and discussed her research on the impact of employment on cancer patients' health insurance decisions.

Full Story
Cancer Therapy Advisor

Telisotuzumab Vedotin Yields Durable Responses in c-Met-Expressing NSCLC

news outletCancer Therapy Advisor
Publish DateJune 07, 2024

Telisotuzumab vedotin shows promising activity in previously treated, c-Met-overexpressing, EGFR-wild-type nonsquamous non-small cell lung cancer (NSCLC), as presented by CU Cancer Center member David Ross Camidge, MD, PhD, at the ASCO Annual Meeting 2024. This phase 2 LUMINOSITY trial (NCT03539536) involved 161 patients with advanced or metastatic NSCLC and the overall response rate was 28.6%, with median progression-free survival of 5.7 months and median overall survival of 14.5 months.

Full Story
Association of Cancer Care Centers

The Centralized Tracking and Management of Incidental Lung Nodule Findings

news outletAssociation of Cancer Care Centers
Publish DateJune 07, 2024

The University of Colorado Cancer Center has been honored with the 2024 ACCC Innovator Award for creating a community-wide safety net for the centralized tracking and management of incidental lung nodule findings. This innovative approach led to a 2,514% increase in actively managed patients. To handle this surge, the center employs enterprise intelligence software to automatically analyze imaging results and identify high-risk patients, reducing patient wait times from 34 days to 5 days. ACCCBuzz interviewed Nina Thomas, MD, director of the Thoracic Malignancy Pillar, to discuss this achievement.

Full Story